Social Media Twitter Facebook Linked In RSS Feed Podcasts

MUNICH – Biotechnology company Insempra has announced a strategic investment in synthetic biology company Solena in a bid to accelerate the development of “naturally superior” materials.

Solena, a spin-out from Imperial College London, develops synthetic proteins for high-performance clothing fibres which subsequently have a lesser impact on the environment than conventional textiles. 

Jens Klein, founder and CEO of Insempra and CEO of Solena Materials, commented: “We are hugely excited by this investment in Solena, which will help to accelerate our market-first approach to develop superior, intrinsically sustainable ingredients.”

Why Subscribe ?

Back Issue Archive
Other Publications from MCL News & Media

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap